Literature DB >> 4703097

Acute renal failure associated with combined gentamicin and cephalothin therapy.

J P Fillastre, R Laumonier, G Humbert, D Dubois, J Metayer, A Delpech, J Leroy, M Robert.   

Abstract

Three patients with normal renal function developed acute renal failure between the ninth and twenty-seventh days of combined gentamicin and cephalothin therapy. The dose of gentamicin (4-6 mg/kg/day) was in the normal range, but that of cephalothin (180 mg/kg/day) was abnormally high. The nephropathy was of the tubular-interstitial type and the clinical picture similar to that seen in acute drug-induced nephropathies. Frusemide was given only after the onset of renal failure. In these three patients the high intravenous doses of cephalothin combined with gentamicin were probably nephrotoxic.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4703097      PMCID: PMC1589978          DOI: 10.1136/bmj.2.5863.396

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  6 in total

1.  LABORATORY AND CLINICAL STUDIES OF GENTAMICIN, A NEW BROAD-SPECTRUM ANTIBIOTIC.

Authors:  R J BULGER; S SIDELL; W M KIRBY
Journal:  Ann Intern Med       Date:  1963-11       Impact factor: 25.391

2.  [Acute renal failure following gentamicin-cephalosporin association therapy].

Authors:  A Opitz; I Herrmann; D van Herrath; K Schaefer
Journal:  Med Welt       Date:  1971-03-13

3.  Treatment of bacterial endocarditis with cephalothin.

Authors:  J J Rahal; B R Meyers; L Weinstein
Journal:  N Engl J Med       Date:  1968-12-12       Impact factor: 91.245

4.  Declining renal function associated with administration of cephalothin.

Authors:  M J Pickering; G R Spooner; A de Quesada; J R Cade
Journal:  South Med J       Date:  1970-04       Impact factor: 0.954

5.  Nephrotoxicity and acute renal failure associated with cephalothin and cephaloridine.

Authors:  I J Simpson
Journal:  N Z Med J       Date:  1971-11

6.  Relative nephrotoxicity of cephalosporin antibiotics in an animal model.

Authors:  A L Linton; R R Bailey; D I Turnbull
Journal:  Can Med Assoc J       Date:  1972-09-09       Impact factor: 8.262

  6 in total
  22 in total

1.  Synergy between cephalosporin and aminoglycoside antibiotics against Providencia and Proteus.

Authors:  P J Hyams; M S Simberkoff; J J Rahal
Journal:  Antimicrob Agents Chemother       Date:  1974-06       Impact factor: 5.191

2.  Postoperative chronic renal failure: a new syndrome?

Authors:  G E Merino; T J Buselmeier; C M Kjellstrand
Journal:  Ann Surg       Date:  1975-07       Impact factor: 12.969

3.  Editorial: Confusion amongst the cephalosporins.

Authors:  R Wise
Journal:  Can Med Assoc J       Date:  1976-07-03       Impact factor: 8.262

4.  Acute interstitial nephritis and non-oliguric renal failure after cefaclor treatment.

Authors:  W Pommer; P H Krause; P A Berg; H H Neumayer; M J Mihatsch; M Molzahn
Journal:  Klin Wochenschr       Date:  1986-03-17

5.  Renal failure in combined gentamicin and cephalothin therapy.

Authors: 
Journal:  Br Med J       Date:  1973-06-30

6.  Tobramycin nephrotoxicity. A prospective clinical study.

Authors:  A Coca; J Blade; A Martinez; F Segura; E Soriano; M Ribas-Mundo
Journal:  Postgrad Med J       Date:  1979-11       Impact factor: 2.401

7.  Empiric therapy for cancer patients: comparative study of ticarcillin-tobramycin, ticarcillin-cephalothin, and cephalothin-tobramycin.

Authors:  J Klastersky; C Hensgens; L Debusscher
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

8.  [Studies on the in vitro effects of cephalothin and gentamicin, alone and in combination, on proteus mirabilis and enterococci (author's transl)].

Authors:  H Lode
Journal:  Infection       Date:  1975       Impact factor: 3.553

9.  Tobramycin nephrotoxicity: failure of cefotaxime to potentiate renal toxicity.

Authors:  J Kuhlmann; G Seidel; H Grötsch
Journal:  Infection       Date:  1982       Impact factor: 3.553

10.  Gentamicin- and cephalothin-associated rises in blood urea nitrogen.

Authors:  W L Fanning; D Gump; H Jick
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.